GROUP B AND G BETA-HEMOLYTIC STREPTOCOCCI IN POMURJE REGION – CHARACTERISTICS OF ANTIMICROBIAL RESISTANT ISOLATES
Abstract
Background. Macrolide-resistant strains of betahemolytic streptococci have been isolated in Pomurje region in Slovenia. The aim of the study was to determine phenotypes of macrolide-lincozamide resistance and patterns of resistance to selected antibiotics in these isolates.
Methods. Twenty-one erythromycin-resistant isolates from group B and group G beta-hemolytic streptococci, obtained from patients in Pomurje were analyzed. Phenotypes of macrolide-lincozamide resistance were determined in all isolates. In group B and group G streptococci susceptibility to 8 and 14 antibiotics was tested, respectively.
Results. All 42 isolates were susceptible to penicillin and vancomycin. The majority of erythromycin-resistant group B streptococci isolates was tetracycline-resistant but susceptible to chloramphenicol and ofloxacin. In erythromycin-resistant isolates of group G streptococci 5 different resistance patterns were found. The most frequent pattern was a resistance to multiple antibiotics (besides erythromycin also to midekamycin, clindamycin, tetracycline, chloramphenicol and several fluoroquinolones).
Conclusions. These resistant isolates are unique and represent novel example of a strong bacterial ability to adapt to changes in their environment and consequently survive in the presence of antibiotics.
Downloads
References
Ruoff KL. Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of clinical microbiology. 7th ed. Washington: ASM, 1999: 283–96.
Cornaglia G. Macrolide resistance and Streptococcus pyogenes: molecular basis, epidemiology and clinical significance. Rev Med Microbiol 1999; 10: 245–58.
Portillo A, Lantero M, Olarte I, Ruiz-Larrea F, Torres C. MLS resistance phenotypes and mechanisms in beta-haemolytic group B, C and G streptococcus isolates in La Rioja, Spain. J Antimicrob Chemother 2001; 47: 115–6.
Fitoussi F, Loukil C, Gros I et al. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 2001; 45: 1889–91.
Wu JJ, Lin KY, Hsueh PR, Liu JW, Pan HI, Sheu SM. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 2001; 45: 3205–8.
Wu JJ, Lin KY, Hsueh PR, Liu JW, Pan HI, Sheu SM. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother 1997; 41: 844–6.
Kataja J, Seppala H, Skurnik M, Sarkkinen H, Huovinen P. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother 1998; 42: 1493–4.
Kolman J, Štorman A, Žohar-Čretnik T et al. Pogled v odpornost betahemolitičnih streptokokov in zunajbolnišničnih sevov Staphylococcus aureus. Med Razgl 1999; 38: Suppl 2: 7–23.
Štrumbelj I. Proti eritromicinu odporni sevi betahemolitičnih streptokokov skupin A, B in G v Pomurju, 1997–2000. In: Mueller-Premru M, Gubina M eds. Mikrobi in antibiotiki 2001. Zbornik predavanj Mikrobiološki simpozij z mednarodno udeležbo. Ljubljana: Slovensko zdravniško društvo, Sekcija za klinično mikrobiologijo in hospitalne infekcije, 2001: 139–44.
NCCLS. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement. Document M100-S12. Villanova, PA: NCCLS, 2002.
Esposito S, Noviello S, Ianniello F, Novelli A. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus. Chemotherapy 2000; 46: 23–7.
Yan SS, Fox ML, Holland SM, Stock F, Gill VJ, Fedorko DP. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob Agents Chemother 2000; 44: 3196–8.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
